跳至主要内容
临床试验/ACTRN12617000354381
ACTRN12617000354381已完成未知

An investigation examining the efficacy and safety of a multi-nutrient intervention on symptoms of antenatal depression and anxiety in pregnant women who are symptomatic: A double blind, randomized, controlled trial

Professor Julia Rucklidge0 个研究点目标入组 88 人开始时间: 2017年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
Female

入选标准

  • 1) women aged 16 years and over; 2) 12-24 weeks gestation; 3) low risk singleton pregnancy; 4) free from psychiatric medication for four weeks; 5) score of 13 or more on the Edinburgh Postnatal Depression Scale (EPDS); 6) deemed reliable and compliant with the protocol.
  • Reference group inclusion criteria:
  • 1) pregnant women aged 16 years and over; 2) low risk singleton pregnancy

排除标准

  • 1) regular vomiting; 2) high risk pregnancy; 3) significant pregnancy complications; 4) known foetal abnormalities; 5) serious current or historical medical condition; 6) known allergy to the ingredients of the intervention; 7) known metabolic condition such as Wilson’s disease, hemochromatosis.; 8) untreated or unstable thyroid disease; 9) known neurological disorder; 10) desire to continue taking prenatal supplements that either exceed the upper limit or are not required for medical purposes (decisions discussed and made on a case-by-case basis)

研究者

发起方
Professor Julia Rucklidge

相似试验